From beef stew to biologics

Photos by Johanna Carson

Oregon Freeze Dry is expanding its operations in the biopharmaceutical sphere, aiming to take a bite out of a $400 billion global market that includes vaccines and biotherapeutics. Last fall, the company opened a state-of-the-art $7.5 million development and clinical supply facility at its headquarters in Albany.